The creditors got paid with the money LCYB paid for Former BioAmbers patents. All of the patents that used to be owned by BioAmber are now owned by LCY Biosciences as shown here. Bioamber no longer owns any patents or any assets for that matter so former BioAmber shareholders will not receive any money at all. LCYB has no reason to pay former BioAmber shareholders anything and they even wrote a letter stating that as well. https://legacy-assignments.uspto.gov/assignments/assignment-pat-51062-55.pdf